Illuminating the druggable genome: Pathways to progress
Drug Discovery Today,
Journal Year:
2023,
Volume and Issue:
29(3), P. 103805 - 103805
Published: Oct. 27, 2023
There
are
∼4500
genes
within
the
'druggable
genome',
subset
of
human
genome
that
expresses
proteins
able
to
bind
drug-like
molecules,
yet
existing
drugs
only
target
a
few
hundred.
A
substantial
druggable
largely
uncharacterized
or
understudied,
with
many
falling
G
protein-coupled
receptor
(GPCR),
ion
channel,
and
kinase
protein
families.
To
improve
scientific
understanding
these
three
understudied
families,
US
National
Institutes
Health
launched
Illuminating
Druggable
Genome
Program.
Now,
as
it
draws
close,
this
review
will
lay
out
resources
developed
by
program
intended
equip
community
tools
necessary
explore
previously
biology
potential
rapidly
impact
health.
Language: Английский
Kinome state is predictive of cell viability in pancreatic cancer tumor and cancer-associated fibroblast cell lines
PeerJ,
Journal Year:
2024,
Volume and Issue:
12, P. e17797 - e17797
Published: Aug. 28, 2024
Numerous
aspects
of
cellular
signaling
are
regulated
by
the
kinome-the
network
over
500
protein
kinases
that
guides
and
modulates
information
transfer
throughout
cell.
The
key
role
played
both
individual
assemblies
organized
into
functional
subnetworks
leads
to
kinome
dysregulation
driving
many
diseases,
particularly
cancer.
In
case
pancreatic
ductal
adenocarcinoma
(PDAC),
a
variety
associated
pathways
have
been
identified
for
their
in
establishment
disease
as
well
its
progression.
However,
identification
additional
relevant
therapeutic
targets
has
slow
is
further
confounded
interactions
between
tumor
surrounding
microenvironment.
this
work,
we
attempt
link
state
human
kinome,
or
kinotype,
with
cell
viability
treated,
patient-derived
PDAC
cancer-associated
fibroblast
lines.
We
applied
classification
models
independent
perturbation
kinase
inhibitor
screen
data,
found
inferred
kinotype
significant
predictive
relationship
viability.
find
able
identify
set
whose
behavior
response
drive
majority
responses
these
lines,
including
understudied
CSNK2A1/3,
CAMKK2,
PIP4K2C.
next
utilized
predict
new,
clinical
inhibitors
were
not
present
initial
dataset
model
devlopment
conducted
validation
confirmed
accuracy
models.
These
results
suggest
characterizing
perturbed
provides
opportunity
better
understanding
downstream
phenotypes,
providing
insight
broader
design
potential
strategies
PDAC.
Language: Английский
Kinase Drug Discovery: Impact of Open Science and Artificial Intelligence
Molecular Pharmaceutics,
Journal Year:
2024,
Volume and Issue:
21(10), P. 4849 - 4859
Published: Sept. 6, 2024
Given
their
central
role
in
signal
transduction,
protein
kinases
(PKs)
were
first
implicated
cancer
development,
caused
by
aberrant
intracellular
signaling
events.
Since
then,
PKs
have
become
major
targets
different
therapeutic
areas.
The
preferred
approach
to
intervention
of
PK-dependent
diseases
is
the
use
small
molecules
inhibit
catalytic
phosphate
group
transfer
activity.
PK
inhibitors
(PKIs)
are
among
most
intensely
pursued
drug
candidates,
with
currently
80
approved
compounds
and
several
hundred
clinical
trials.
Following
elucidation
human
kinome
development
robust
expression
systems
high-throughput
assays,
large
volumes
PK/PKI
data
been
produced
industrial
academic
environments,
more
so
than
for
many
other
pharmaceutical
targets.
In
addition,
hundreds
X-ray
structures
complexes
PKIs
reported.
Substantial
amounts
made
publicly
available
part
as
a
result
open
science
initiatives.
discovery
further
supported
through
incorporation
approaches,
including
various
specialized
databases
online
resources.
Compound
activity
wealth
compared
has
also
focal
point
application
artificial
intelligence
(AI)
research.
Herein,
we
discuss
interplay
review
exemplary
studies
that
substantially
contributed
its
profiling
or
analysis
PKI
promiscuity
versus
selectivity.
We
take
close
look
at
how
AI
approaches
beginning
impact
light
increasing
orientation.
Language: Английский
Assessing Darkness of the Human Kinome from a Medicinal Chemistry Perspective
Selina Voßen,
No information about this author
Elena Xerxa,
No information about this author
Jürgen Bajorath
No information about this author
et al.
Published: Aug. 22, 2024
In
drug
discovery,
human
protein
kinases
(PKs)
represent
one
of
the
major
target
classes,
due
to
their
central
role
in
cellular
signaling,
implication
various
diseases
as
a
consequence
deregulated
and
notable
druggability.
Individual
PKs
disease
biology
have
been
explored
different
degrees,
giving
rise
heterogeneous
functional
knowledge
associations
across
kinome.
The
U.S.
National
Institutes
Health
previously
designated
162
understudied
(“dark”)
lipid
kinases,
lack
annotations
high-quality
molecular
probes
for
investigations.
Given
large
volumes
available
PK
inhibitors
(PKIs)
activity
data,
we
systematically
analyzed
distribution
PKIs
associated
data
at
confidence
levels
kinome
distinguished
between
chemically
explored,
underexplored,
unexplored
PKs.
analysis
provides
medicinal
chemistry-centric
view
exploration
further
extends
prior
assessment
dark
Language: Английский
Assessing Darkness of the Human Kinome from a Medicinal Chemistry Perspective
Selina Voßen,
No information about this author
Elena Xerxa,
No information about this author
Jürgen Bajorath
No information about this author
et al.
Journal of Medicinal Chemistry,
Journal Year:
2024,
Volume and Issue:
67(19), P. 17919 - 17928
Published: Sept. 25, 2024
In
drug
discovery,
human
protein
kinases
(PKs)
represent
one
of
the
major
target
classes
due
to
their
central
role
in
cellular
signaling,
implication
various
diseases
as
a
consequence
deregulated
and
notable
druggability.
Individual
PKs
disease
biology
have
been
explored
different
degrees,
giving
rise
heterogeneous
functional
knowledge
associations
across
kinome.
The
U.S.
National
Institutes
Health
previously
designated
162
understudied
("dark")
lipid
lack
annotations
high-quality
molecular
probes
for
investigations.
Given
large
volumes
available
PK
inhibitors
(PKIs)
activity
data,
we
systematically
analyzed
distribution
PKIs
associated
data
at
confidence
levels
kinome
distinguished
between
chemically
explored,
underexplored,
unexplored
PKs.
analysis
provides
medicinal
chemistry-centric
view
exploration
further
extends
prior
assessment
dark
Language: Английский